Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer
Metrics: PDF 618 views | HTML 1172 views | ?
Fei Peng1,*, Hui Li2,*, Hailang Xiao3, Ling Li3, Yan Li4 and Yi Wu1
1Department of Laboratory, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People’s Hospital, Changsha, China
2Reproductive Department, Xiangya Hospital, Central South University, Changsha, China
3Nephrology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People’s Hospital, Changsha, China
4Department of Paediatrics, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People’s Hospital, Changsha, China
*These authors have contributed equally to this work
Yi Wu, email: firstname.lastname@example.org
Keywords: BLCA; miRNA; prognosis; biomarker; TCGA
Received: November 23, 2016 Accepted: June 20, 2017 Published: November 06, 2017
There is not a good biomaker that is closely related to survival time for bladder cancer(BLCA), The aim of the study is to identify a miRNA signature that could predict prognosis in BLCA patients according to the data from The Cancer Genome Atlas (TCGA). a total of 377 BLCA patients were finally enrolled in the study. The three miRNA signature was identified by Multivariate Cox proportional hazards analyses that common clinical variables were controled. The three microRNA signature showed greater predicting prognosis capacity for predicting 5-year survival in BLCA with an AUC of 0.664, 0.681 and 0.668 in Train set, Test set and Total set respectively. Furthermore, there was a significant difference between high score and low score in Total set(P=3e-05), Test set(P=0.00435) and Train set(P=0.00143), respectively. Therefore, these results provided a new prospect for prognostic biomarker of BLCA.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.